Clinical trial
Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received…
NCT00003743 · St. Anna Kinderkrebsforschung, Other · Unknown status
Key facts
| NCT number | NCT00003743 |
|---|---|
| Title | Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation |
| Official title | Multicenter Observer-Blind Randomized Phase II Parallel Study Comparing Three Doses of Subcutaneous Interleukin 2 After Megatherapy and Peripheral Stem Cell Reinfusion in Stage 4 Neuroblastoma in Patients Over 1 Year of Age |
| Lead sponsor | St. Anna Kinderkrebsforschung, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Biological |
| Interventions | aldesleukin |
| Enrollment | 25 |
| Start date | Mar 1, 1997 |
| First posted | Jul 16, 2004 |
| Last update posted | Sep 17, 2013 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: